{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:00:34Z","timestamp":1770220834597,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jsat.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T12:31:14Z","timestamp":1356093074000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine"],"prefix":"10.1016","volume":"44","author":[{"given":"Tami L.","family":"Mark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Dilonardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Vandivort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2012.11.004_bb0005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1360-0443.2009.02539.x","article-title":"Comparison of costs and utilization among buprenorphine and methadone patients","volume":"104","author":"Barnett","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2012.11.004_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.11.004_bb0015","author":"Centers for Disease Control"},{"key":"10.1016\/j.jsat.2012.11.004_bb0020","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","article-title":"The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine","volume":"30","author":"Clark","year":"2011","journal-title":"Health Affairs (Millwood)"},{"key":"10.1016\/j.jsat.2012.11.004_bb0025","series-title":"Misuse of prescription drugs: Data from the 2002, 2003 and 2004 national surveys on drug use and health. DHHS Publication No. SMA06-1492, Analytic Series A-28","author":"Culliver","year":"2006"},{"key":"10.1016\/j.jsat.2012.11.004_bb0030","series-title":"Clinical classifications for health policy research, version 2: Hospital inpatient statistics. Healthcare Cost and Utilization Project (HCUP 3) Research Note 1. AHCPR Pub. No. 96 0017","author":"Elixhauser","year":"1996"},{"key":"10.1016\/j.jsat.2012.11.004_bb0035","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2012.11.004_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AJP.0b013e31815ca2b4","article-title":"Buprenorphine: New tricks with an old molecule for pain management","volume":"24","author":"Heit","year":"2008","journal-title":"Clinical Journal of Pain"},{"key":"10.1016\/j.jsat.2012.11.004_bb0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10550880903182986","article-title":"The \u201cblack box\u201d of prescription drug diversion","volume":"28","author":"Inciardi","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2012.11.004_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.11.004_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-199306000-00004","article-title":"Buprenorphine versus methadone maintenance for opioid dependence","volume":"181","author":"Kosten","year":"1993","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2012.11.004_bb0060","series-title":"Reimbursement of mental health services in primary care settings (HHS Pub. No. SMA-08-4324)","author":"Kautz","year":"2008"},{"key":"10.1016\/j.jsat.2012.11.004_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2012.11.004_bb0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","volume":"53","author":"Ling","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2012.11.004_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomised clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2012.11.004_bb0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1465-3362.2010.00271.x","article-title":"Prescription opioid abuse, pain and addiction: clinical issues and implications","volume":"30","author":"Ling","year":"2011","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2012.11.004_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.11.004_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11533120-000000000-00000","article-title":"For what diagnoses are psychotropic medications being prescribed?: A nationally representative survey of physicians","volume":"24","author":"Mark","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jsat.2012.11.004_bb0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1377\/hlthaff.2010.1024","article-title":"Proportion of antidepressants prescribed without a psychiatric diagnosis is growing","volume":"30","author":"Mojtabai","year":"2011","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2012.11.004_bb0100","author":"RED BOOK"},{"key":"10.1016\/j.jsat.2012.11.004_bb0105","series-title":"Results from the 2009 National Survey on Drug Use and Health: Volume II. Technical appendices and selected prevalence tables. NSDUH series H-38B, HHS publication No. SMA 10\u20134856 Appendices","author":"Office of Applied Studies","year":"2010"},{"key":"10.1016\/j.jsat.2012.11.004_bb0110","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1360-0443.2007.01759.x","article-title":"Persistent pain is associated with substance use after detoxification: A prospective cohort analysis","volume":"102","author":"Paasche-Orlow","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2012.11.004_bb0115","first-page":"5","article-title":"Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation","volume":"20","author":"Passik","year":"2006","journal-title":"Journal of Pain & Palliative Care"},{"key":"10.1016\/j.jsat.2012.11.004_bb0120","unstructured":"Reckitt Benckiser Pharmaceuticals Inc. (2010). Retrieved on January 19, 2012, http:\/\/www.suboxone.com\/pdfs\/SuboxonePI.pdf"},{"key":"10.1016\/j.jsat.2012.11.004_bb0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/002204261004000307","article-title":"Prescription drug abuse & diversion: Role of the pain clinic","volume":"40","author":"Rigg","year":"2010","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.jsat.2012.11.004_bb0130","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2012.11.004_bb0135","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.jsat.2012.11.004_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2003.08.007","article-title":"Treatment needs associated with pain in substance use disorder patients: Implications for concurrent treatment","volume":"73","author":"Trafton","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.11.004_bb0145","author":"United Nations Office on Drugs and Crime"},{"key":"10.1016\/j.jsat.2012.11.004_bb0150","author":"United States Food and Drug Administration"},{"key":"10.1016\/j.jsat.2012.11.004_bb0155","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jpain.2009.03.019","article-title":"Opioid prescribing practices in chronic pain management: Guidelines do not sufficiently influence clinical practice","volume":"10","author":"Victor","year":"2009","journal-title":"Journal of Pain"},{"issue":"12","key":"10.1016\/j.jsat.2012.11.004_bb0160","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine\u2013naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.jsat.2013.06.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000}}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212004266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212004266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:37:34Z","timestamp":1760038654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547212004266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0740547212004266"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2012.11.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2012.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}